News
Pharma Packaging To Be Driven By Sustainability In 2023
Like every other consumer packaged market, pharmaceuticals has also gone on to experience a reckoning with its ecological footprint, mostly in the more consumer-facing element of packaging.
It is well to be noted that consumer preferences as well as governmental...
Drug Research
EMA Releases Mid-Point Regulatory Science Strategy Study
The European Medicines Agency (EMA) has released a paper summarizing its Regulatory Science Strategy (RSS) mid-point achievements through 2025. Originally released in March 2020, the strategy outlines a five-year goal for advancing regulatory science.
Regulatory science belongs to the scientific...
Drug Research
Nasal Spray Effective Against Recent Variants – Research
Researchers have identified a molecule that is particularly successful in preventing sickness caused by all known forms of the SARS-CoV-2 virus when put nasally. The molecule could be a valuable tool in preparing for future pandemics because it is...
News
10 Benefits Of Taking Probiotics
Probiotics are the third-most consumed dietary supplement in the United States. So, what are probiotics, and how do they help your body?
Your body is home to lots of bacteria, not all of which are bad. Some bacteria harm your...
IT & Data Management
Citeline Finalist CluePoints Show Advanced AI Capabilities
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category.
The...
Drug Research
First Gene Therapy Comes Into Picture For AADC Deficiency
In the final draft guidance rolled out by the National Institute for Health and Care Excellence- NICE, a single-dose therapy, eladocagene exuparvovec, has been recommended for patients who are more than 18 months old and happen to be suffering...
Drug Research
Australia Offers Hope For Drug Resistant Epilepsy Patients
More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the condition with the anti-seizure medications that are currently in use. The patients with such drug-resistant...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read